Can a mast cell subtype (MCT) play a role in the progression of endometrial cancer through angiogenesis?

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 6, 2006, Pages

  Özdemir, Öner ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; THYMIDINE PHOSPHORYLASE; VASCULOTROPIN;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CELL TYPE; DISEASE MARKER; ENDOMETRIUM CANCER; HUMAN; LETTER; LIVER CARCINOMA; MAST CELL; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR VASCULARIZATION;

DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MAST CELLS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 33751343916     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.02.016     Document Type: Letter

References (4)

1. Ribatti D., Finato N., Crivellato E., Marzullo A., Mangieri D., Nico B., et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 193 (2005) 1961-1965
2. Özdemir O. Mast cell density, angiogenesis and their significance in tumor development. Gynecol Oncol 100 (2006) 628-629
3. D'Souza O.A., Rameshkumar K., and Nirmala V. Mast cells and macrophages in endometrial lesions. Indian J Pathol Microbiol 37 (1994) 367-373
4. Saad R.S., Jasnosz K.M., Tung M.Y., and Silverman J.F. Endoglin (CD105) expression in endometrial carcinoma. Int J Gynecol Pathol 22 (2003) 248-253